Friday, April 15, 2022

Regeneron used Cuomo connections to get R&D chief Yancopoulos early COVID testing: NYT


New York Governor Andrew Cuomo has been embroiled in numerous controversies in recent weeks, and now a high-profile pharma company has been swept into the melee.

Regeneron’s president and chief scientific officer, George Yancopoulos, was among the people who snagged access to COVID-19 testing early in the pandemic when testing was limited, The New York Times reports. Aside from Yancopoulos, Cuomo allowed his relatives and other “influential people” access to testing, the NYT reports.  

Regeneron sought tests for Yancopoulos after a member of his family contracted COVID-19, a spokeswoman told the Times. Yancopoulos was an essential worker who “directly led” Regeneron’s work to develop its COVID-19 antibody cocktail, she added, so the company asked for testing to ensure its teams would be safe.

Early in the pandemic, there was a “heavy emphasis on contact tracing,” a spokesman for the governor told the Times. The administration was “absolutely going above and beyond to get people tested,” he added. Lawmakers, reporters and members of the general public were among those who were tested, he said. 

RELATED: Regeneron, Roche’s COVID-19 antibody cocktail could snare $6B in sales next year: analyst

Meanwhile, the New York State Assembly’s judiciary committee has been looking into allegations of sexual harassment against the governor, and into allegations that his administration manipulated data on nursing home deaths during the pandemic. Investigators could now look into the early testing access, the committee’s chair Charles D. Lavine told the Times. 

Regeneron has played an important role in the pandemic response by developing an antibody cocktail to an emergency use authorization from the FDA. Phase 3 data recently showed the combo lowered the risk of hospitalization or death in high-risk, non-hospitalized patients by 70% compared with placebo. 

RELATED: Regeneron, Roche COVID-19 antibody cocktail slashes hospitalizations and tackles variants in phase 3

In addition, the company previously pledged to provide New York with 500,000 test kits at no charge.  



Source link

Latest Articles

Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Foods to Reduce Inflammation and Strengthen the Immune System

Did you know that you can greatly reduce inflammation and boost your immune system by simply incorporating more anti-inflammatory foods and beverages into your...

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...